SEC Form 4 · accession 0001615774-15-002381
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Smith
Director
Period of report
Aug 20, 2015
Accepted (ET)
Aug 24, 2015 · 6:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2015 | A | 750,000 | $0.00 | A | 750,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF2 | $0.055 | Aug 20, 2015 | A | 250,000 | A | — | Aug 19, 2025 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1Represents a grant of shares of restricted stock vesting pro rata over 36 months begining on August 20, 2015.
- F2These options vest pro rata over 36 months beginning on August 20, 2015.